Since the pandemic started, I understand bookings on your travel platforms have plunged more than 80 percent. You've already suspended share buybacks and you've already raised some $4 billion in debts from investors, give us an idea of the cash position you're in right now, and how long a runway does it give you?

GF: Yes, in the second quarter, we did our earnings announcement and we are absolutely fine. Financially, absolutely there's no liquidity problem at all, at all. But that being said, it's not just good enough to not run out of cash. That's not the game, that's not what we're trying to achieve. We're trying to achieve profits in the long run. We're trying to develop a company that in the long run is producing a great service. I do feel that one of the advantages of our companies is that we are so much better capitalised and our liquidity is so much better than some of our competitors. It really is a competitive advantage.

CT: So, how long a runway does it give you, you think, gut feel?

GF: There's not a drain right now. It's not like there's some sort of cash outflow that we have to worry about right now. The element is not a case of a burn rate, like if in three years, if things don't turn around, you're going to run out of money. Thank God, we're nowhere near one of those types of situations.

CT: You've been quoted saying, it's going to take you years before the travel market actually returns to pre-pandemic levels. Give us an idea of what sort of timeframe, what's the earliest timeframe you're looking at?

GF: I think everybody has fun guessing when is that going to be? The truth is, nobody knows because it's so dependent on a couple variables that are just guesses. The first thing is safety. Do people feel safe going on a trip or not? What is going to determine that is, is there a vaccine? Are there effective treatments? Is there herd immunity? Let's say, there's an announcement in the next few months that there is one or more than one vaccine that is effective and considered to be safe, we know there's a high probability given the number of pharmaceutical companies that are doing phase three trials right now, I wouldn't put that as a low probability, I put that as a good probability, but then you still have to distribute it, you got to get that actual drug out to a huge number of people around the world. People are going to be a little bit nervous about traveling until they feel that everybody knows people have been inoculated, so it's safe to travel. And nobody knows that, because nobody really knows when will that level of immunity from a vaccine actually hit the right level that people feel, okay, everything is good? Everybody's guessing, you've heard my guess already, I'm not going to change it, but I'll certainly say that I don't think anybody expects it to be anytime soon, that's for sure.

Read the full article at cnbc.com